Assenagon Asset Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$361K Hold
27,727
﹤0.01% 1099
2026
Q1
$315K Sell
27,727
-209,353
-88% -$2.27M ﹤0.01% 1049
2025
Q4
$3.04M Sell
237,080
-56,145
-19% -$693K ﹤0.01% 764
2025
Q3
$3.28M Sell
293,225
-19,482
-6% -$188K ﹤0.01% 710
2025
Q2
$3.1M Buy
312,707
+72,826
+30% +$713K ﹤0.01% 661
2025
Q1
$2.25M Sell
239,881
-32,426
-12% -$341K ﹤0.01% 735
2024
Q4
$2.49M Sell
272,307
-152,801
-36% -$1.12M ﹤0.01% 879
2024
Q3
$3.31M Buy
425,108
+28,499
+7% +$206K 0.01% 821
2024
Q2
$2.4M Sell
396,609
-414,723
-51% -$2.56M 0.01% 836
2024
Q1
$4.76M Sell
811,332
-242,690
-23% -$1.44M 0.01% 621
2023
Q4
$8.26M Hold
1,054,022
0.02% 500
2023
Q3
$7.7M Buy
1,054,022
+486,501
+86% +$4.05M 0.02% 449
2023
Q2
$5.92M Sell
567,521
-106,985
-16% -$1.03M 0.02% 462
2023
Q1
$6.97M Buy
674,506
+529,145
+364% +$6.77M 0.02% 481
2022
Q4
$2M Buy
145,361
+130,118
+854% +$1.81M 0.01% 809
2022
Q3
$312K Buy
+15,243
New +$335K ﹤0.01% 1196
2022
Q1
Sell
-22,582
Closed -$623K 1411
2021
Q4
$623K Sell
22,582
-43,004
-66% -$1.19M ﹤0.01% 1156
2021
Q3
$1.7M Sell
65,586
-12,479
-16% -$334K 0.01% 749
2021
Q2
$2.12M Sell
78,065
-33,575
-30% -$820K 0.01% 656
2021
Q1
$2.61M Hold
111,640
0.01% 653
2020
Q4
$1.71M Sell
111,640
-554,946
-83% -$7.04M 0.01% 565
2020
Q3
$8.04M Buy
666,586
+140,286
+27% +$1.33M 0.05% 236
2020
Q2
$5.35M Buy
526,300
+253,343
+93% +$2.61M 0.03% 317
2020
Q1
$2.85M Sell
272,957
-12,005
-4% -$151K 0.02% 294
2019
Q4
$4.56M Buy
284,962
+230,262
+421% +$3.52M 0.03% 253
2019
Q3
$1.01M Buy
54,700
+38,400
+236% +$751K 0.01% 547
2019
Q2
$321K Buy
+16,300
New +$332K ﹤0.01% 910

Other funds holding ANGO

Assenagon Asset Management's ANGO Position: Q2 2026 in Review

Assenagon Asset Management held its AngioDynamics (ANGO) position steady in Q2 2026 at 27,727 shares worth $361K. The position accounts for ﹤0.01% of the portfolio, ranked #1099.

Assenagon Asset Management first reported a position in ANGO in Q2 2019 and has held it in 27 quarters since. The position peaked at $8.26M in Q4 2023. 10 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Assenagon Asset Management held 27,727 shares of AngioDynamics worth $361K as of Q2 2026.
  • Assenagon Asset Management left its AngioDynamics share count unchanged in Q2 2026.
  • AngioDynamics made up ﹤0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #1099 holding.
  • Assenagon Asset Management first reported a position in AngioDynamics in Q2 2019 and has held it in 27 quarters since.
  • Assenagon Asset Management's AngioDynamics position peaked at $8.26M in Q4 2023.
  • 10 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.